Clinical Trials
10 trialsNCT05199584 2026-03-05
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Phase 2 Completed
NCT03636568 2024-07-23
DHAPS
Washington University School of Medicine
Phase NA Completed
NCT02357498 2019-11-25
TRANSSPHER
St. Joseph's Hospital and Medical Center, Phoenix
Phase NA Completed
NCT00054756 2018-08-08
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02084134 2018-04-11
Steroid
Washington University School of Medicine
Phase NA Completed
NCT00936741 2014-04-02
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Corcept Therapeutics
Phase 3 Completed
NCT01371565 2014-03-18
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Corcept Therapeutics
Phase 3 Completed
NCT00569582 2013-08-22
SEISMIC
Corcept Therapeutics
Phase 3 Completed
NCT00306683 2011-02-18
Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT00136032 2008-02-18
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
Massachusetts General Hospital
Phase NA Completed